Literature DB >> 26319539

A case of hepatocellular carcinoma treated by radiofrequency ablation confirming the adjacent major bile duct under hybrid contrast mode through a biliary drainage catheter.

Yusuke Imai1, Masashi Hirooka2, Hironori Ochi3, Yohei Koizumi1, Yoshinori Ohno1, Takao Watanabe1, Yoshio Tokumoto1, Teru Kumagi1, Masanori Abe1, Yoichi Hiasa1.   

Abstract

Bile duct injury is a potential complication of radiofrequency ablation (RFA). Bipolar RFA devices have recently become available. Because visibility of the bipolar RFA electrodes is not good on ultrasonography, more careful usage of the electrodes to avoid bile ducts is needed. We present a case with hepatocellular carcinoma (HCC) located near the B5 intrahepatic bile duct. To view the bile duct, we used contrast medium for ultrasonography, administered through a biliary drainage catheter for endoscopic nasobiliary drainage (ENBD). Infusing the contrast medium allowed clear visualization of the HCC adjacent to the major bile duct during RFA. We also used a navigation system for bipolar RFA to confirm positions of the electrodes and HCC. We confirmed complete ablation of the HCC while avoiding bile duct injury and late bile duct stenosis. Administration of contrast medium for ultrasonography through an ENBD tube appears useful to avoid bile duct injury during RFA.

Entities:  

Keywords:  Bile duct injury; Hepatocellular carcinoma; Hybrid contrast mode; Navigation system; Radiofrequency ablation

Mesh:

Substances:

Year:  2015        PMID: 26319539     DOI: 10.1007/s12328-015-0599-2

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  17 in total

1.  An evaluation of the protective effect of an infusion of chilled glucose solution on thermal injury of the bile ducts caused by radiofrequency ablation of the liver.

Authors:  Marcelo Salim Talasso; Valéria Lanzoni; Alberto Goldenberg; Rodrigo Gobbo Garcia; Rita Maria Aparecida Moura-Franco; Olívia Oléa Cisnero Fernandes; Rafael de Souza Mesquita; Jorge Roberto Marcante Carlotto; Delcio Matos; Gaspar de Jesus Lopes-Filho; Marcelo Moura Linhares
Journal:  Acta Cir Bras       Date:  2015-01       Impact factor: 1.388

2.  Feasibility of the virtual needle tracking system for percutaneous radiofrequency ablation of hepatocellular carcinoma.

Authors:  Akiko Tomonari; Kunihiko Tsuji; Hajime Yamazaki; Hironori Aoki; Jong-Hon Kang; Yoshihisa Kodama; Yasuo Sakurai; Hiroyuki Maguchi
Journal:  Hepatol Res       Date:  2013-03-19       Impact factor: 4.288

3.  Clinical effectiveness of bipolar radiofrequency ablation for small liver cancers.

Authors:  Yukio Osaki; Kenji Ikeda; Namiki Izumi; Satoyoshi Yamashita; Hiromitsu Kumada; Shinji Hatta; Kiwamu Okita
Journal:  J Gastroenterol       Date:  2012-10-10       Impact factor: 7.527

Review 4.  Complications of radiofrequency coagulation of liver tumours.

Authors:  S Mulier; P Mulier; Y Ni; Y Miao; B Dupas; G Marchal; I De Wever; L Michel
Journal:  Br J Surg       Date:  2002-10       Impact factor: 6.939

5.  Two cases of hepatocellular carcinoma located adjacent to the Glisson's capsule treated by laparoscopic radiofrequency ablation with intraductal chilled saline perfusion through an endoscopic nasobiliary drainage tube.

Authors:  Yasuyuki Nakata; Seiji Haji; Hajime Ishikawa; Takeo Yasuda; Takuya Nakai; Yoshihumi Takeyama; Hitoshi Shiozaki
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2010-12       Impact factor: 1.719

6.  Efficacy of laparoscopic radiofrequency ablation for hepatocellular carcinoma compared to percutaneous radiofrequency ablation with artificial ascites.

Authors:  Masashi Hirooka; Yoshiyasu Kisaka; Takahide Uehara; Kiyotaka Ishida; Teru Kumagi; Yuji Watanabe; Masanori Abe; Bunzo Matsuura; Yoichi Hiasa; Morikazu Onji
Journal:  Dig Endosc       Date:  2009-04       Impact factor: 7.559

7.  Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites.

Authors:  Takahide Uehara; Masashi Hirooka; Kiyotaka Ishida; Atsushi Hiraoka; Teru Kumagi; Yoshiyasu Kisaka; Yoichi Hiasa; Morikazu Onji
Journal:  J Gastroenterol       Date:  2007-04-26       Impact factor: 7.527

8.  Intraductal chilled saline perfusion to prevent bile duct injury during percutaneous radiofrequency ablation for hepatocellular carcinoma.

Authors:  Takaya Ohnishi; Ichiro Yasuda; Youichi Nishigaki; Hideki Hayashi; Kentaro Otsuji; Tsuyoshi Mukai; Masamichi Enya; Salem Omar; Nib Soehendra; Eiichi Tomita; Hisataka Moriwaki
Journal:  J Gastroenterol Hepatol       Date:  2007-08-07       Impact factor: 4.029

9.  Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: an analysis of 3,891 ablations in 2,614 patients.

Authors:  Hiroshi Kasugai; Yukio Osaki; Hiroko Oka; Masatoshi Kudo; Toshihito Seki
Journal:  Oncology       Date:  2007-12-13       Impact factor: 2.935

Review 10.  Contrast-enhanced ultrasonography: advance and current status in abdominal imaging.

Authors:  Yong Eun Chung; Ki Whang Kim
Journal:  Ultrasonography       Date:  2014-09-12
View more
  3 in total

1.  Prevention of major biliary complications by fusion imaging for thermal ablation of malignant liver tumors adjacent to the bile ducts: a preliminary comparative study.

Authors:  Jia Liu; Lu Li; Qingjing Zeng; Rongqin Zheng; Kai Li
Journal:  Abdom Radiol (NY)       Date:  2022-09-19

2.  Improving Ablation Safety for Hepatocellular Carcinoma Proximal to the Hilar Bile Ducts by Ultrasound-MR Fusion Imaging: A Preliminary Comparative Study.

Authors:  Yujia You; Yinglin Long; Ronghua Yan; Liping Luo; Man Zhang; Lu Li; Qingjing Zeng; Kai Li; Rongqin Zheng; Erjiao Xu
Journal:  Front Oncol       Date:  2021-03-01       Impact factor: 6.244

3.  Efficacy of Percutaneous Thermal Ablation Combined With Transarterial Embolization for Recurrent Hepatocellular Carcinoma After Hepatectomy and a Prognostic Nomogram to Predict Survival.

Authors:  Zhuhui Yuan; Yang Wang; Caixia Hu; Wenfeng Gao; Jiasheng Zheng; Wei Li
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.